SiRNA-Mediated Knockdown of TOP2B Protects hiPSC-Derived Cardiomyocytes from Doxorubicin-Induced Toxicity.

hiPSC-derived cardiomyocytes were treated with siRNA to knock down tTopoisomerase-2 beta and were then exposed to doxorubicin.